MedTrace Logo

Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine

NCT05991375 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2023-08-14

No results posted yet for this study

Summary

End-stage renal disease (ESRD) patients are coming for Brachial vein transposition surgery. Patients were randomly allocated using sealed opaque envelope bearing A- (Injection bupivacaine (0.25%) 28 ml plus 2 ml. normal saline) and B-Injection bupivacaine (0.25%) 28 mL plus dexmedetomidine I ug/kg diluted to 2 ml).

Supraclavicular block under ultrasound and nerve stimulator guidance was performed.

Conditions

Interventions

DRUG

DEXmedetomidine

28 mL of Bupivacain 0.25% was mixed with Dexmedetomidine 1 microgram/kg body weight mixed in 2 mL = total volume 30 mL

OTHER

saline

28 mL of Bupivacain 0.25% was mixed with 2 mL of Normal saline = total volume 30 mL

Sponsors & Collaborators

  • Sindh Institute of Urology and Transplantation

    lead OTHER

Principal Investigators

  • Fauzia Ali, FCPS · Professor Dept of Anaesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-04-30
Completion
2021-04-30
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05991375 on ClinicalTrials.gov